SML0223
唑来膦酸 一水合物
≥98% (HPLC), FPP synthase inhibitor, powder
别名:
P,P′-[1-羟基-2-（1H-咪唑-1-基）亚乙基]双膦酸 一水合物, [1-羟基-2-（1H-咪唑-1-基）乙烷-1,1-二基]双（膦酸） 一水合物, 唑来膦酸 一水合物
登录查看公司和协议定价
关于此项目
经验公式（希尔记法）:
C5H10N2O7P2·H2O
CAS Number:
分子量:
290.10
MDL编号:
UNSPSC代码:
12352204
PubChem化学物质编号:
NACRES:
NA.77
Product Name
唑来膦酸 一水合物, ≥98% (HPLC)
质量水平
方案
≥98% (HPLC)
表单
powder
储存条件
desiccated
protect from light
颜色
white to beige
溶解性
H2O: ≥2 mg/mL
储存温度
2-8°C
SMILES字符串
O.OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O
InChI
1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2
InChI key
FUXFIVRTGHOMSO-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
应用
唑来膦酸一水合物用作：
- 作为抑制剂，抑制胶质母细胞瘤、乳腺癌肿瘤细胞 和前列腺癌细胞系LAPC4的增殖
- 与 D,L-丙交酯75：乙交酯25（PLGA）形成缀合物，分析其在股骨远端的骨形成功能
- 作为胶质母细胞瘤细胞中法尼基二磷酸合酶的抑制剂
生化/生理作用
唑来膦酸（唑来膦酸盐）是一种双膦酸盐骨吸收抑制剂，是基焦磷酸（FPP）合成酶的抑制剂，其会导致破骨细胞活性的下游抑制并减少骨吸收和转换。它已被用于治疗绝经后的骨质疏松症，佩吉特病、高钙血症，并结合癌症化疗以治疗已经扩散到骨骼的癌症引起的骨损伤。
唑来膦酸（唑来膦酸盐）是一种骨吸收抑制剂，是基焦磷酸合成酶的抑制剂
制备说明
本品在溶液中极其不稳定，复溶后应尽快使用。如果一定要保存溶液，最多可在2-8ºC下存放24小时。
警示用语：
Warning
危险声明
危险分类
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness
Kim HY, et al.
Experimental & Molecular Medicine, 50(10), 137-137 (2018)
Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cells
Jiang P, et al.
Testing, 7(36), 57932-57932 (2016)
David John Garnett
Journal of cancer research and clinical oncology, 142(3), 611-618 (2015-11-18)
Mevalonate pathway inhibitors are potentially useful chemotherapeutic agents showing growth inhibition and pro-apoptotic effects in cancer cells. The effects of statins and bisphosphonates on cancer growth are attributed to a reduction in protein isoprenylation. Post-translational modification and activation of GTPase
Wei Lei et al.
Scientific reports, 10(1), 7004-7004 (2020-04-26)
The most challenging issue for breast cancer (BC) patients is metastasis to other organs because current therapies do not prevent or eliminate metastatic BC. Here, we show that SM-164, a small molecule inhibitor, which degrades inhibitor of apoptosis proteins (IAPs)
Xu Li et al.
ACS applied materials & interfaces, 11(7), 7311-7319 (2019-01-29)
Bisphosphonates are generally used to treat bone diseases, such as bone metastasis from cancer. There is evidence that, through the modification of the pharmacokinetics and biodistribution of bisphosphonates by formulating them into nanoparticles, they may be able to treat extraskeletal
商品
Discover Bioactive Small Molecules for Lipid Signaling Research
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持